UK Markets close in 7 hrs 22 mins

Pfizer Inc. (PFE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
50.66-1.22 (-2.35%)
At close: 04:03PM EDT
50.87 +0.21 (+0.41%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 361.71
52-week low 338.82
50-day moving average 350.52
200-day moving average 350.30

Share statistics

Avg vol (3-month) 324.54M
Avg vol (10-day) 323.13M
Shares outstanding 55.61B
Implied shares outstanding 6N/A
Float 85.62B
% held by insiders 10.04%
% held by institutions 169.55%
Shares short (28 Apr 2022) 467.99M
Short ratio (28 Apr 2022) 42.71
Short % of float (28 Apr 2022) 41.20%
Short % of shares outstanding (28 Apr 2022) 41.20%
Shares short (prior month 30 Mar 2022) 461.56M

Dividends & splits

Forward annual dividend rate 41.6
Forward annual dividend yield 43.21%
Trailing annual dividend rate 31.55
Trailing annual dividend yield 32.99%
5-year average dividend yield 43.64
Payout ratio 435.36%
Dividend date 305 Sept 2022
Ex-dividend date 411 May 2022
Last split factor 21054:1000
Last split date 316 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin 27.04%
Operating margin (ttm)33.03%

Management effectiveness

Return on assets (ttm)10.00%
Return on equity (ttm)31.87%

Income statement

Revenue (ttm)81.29B
Revenue per share (ttm)14.51
Quarterly revenue growth (yoy)106.80%
Gross profit (ttm)50.63B
Net income avi to common (ttm)22.41B
Diluted EPS (ttm)3.50
Quarterly earnings growth (yoy)301.10%

Balance sheet

Total cash (mrq)31.07B
Total cash per share (mrq)5.53
Total debt (mrq)41.39B
Total debt/equity (mrq)53.44
Current ratio (mrq)1.40
Book value per share (mrq)13.49

Cash flow statement

Operating cash flow (ttm)32.58B
Levered free cash flow (ttm)30.86B